116 related articles for article (PubMed ID: 18215350)
1. Double-mismatched siRNAs enhance selective gene silencing of a mutant ALS-causing allele.
Geng CM; Ding HL
Acta Pharmacol Sin; 2008 Feb; 29(2):211-6. PubMed ID: 18215350
[TBL] [Abstract][Full Text] [Related]
2. Design of functional small interfering RNAs targeting amyotrophic lateral sclerosis-associated mutant alleles.
Geng CM; Ding HL
Chin Med J (Engl); 2011 Jan; 124(1):106-10. PubMed ID: 21362317
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of allele discrimination by introduction of nucleotide mismatches into siRNA in allele-specific gene silencing by RNAi.
Ohnishi Y; Tamura Y; Yoshida M; Tokunaga K; Hohjoh H
PLoS One; 2008 May; 3(5):e2248. PubMed ID: 18493311
[TBL] [Abstract][Full Text] [Related]
4. Designing siRNA that distinguish between genes that differ by a single nucleotide.
Schwarz DS; Ding H; Kennington L; Moore JT; Schelter J; Burchard J; Linsley PS; Aronin N; Xu Z; Zamore PD
PLoS Genet; 2006 Sep; 2(9):e140. PubMed ID: 16965178
[TBL] [Abstract][Full Text] [Related]
5. Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis.
Ding H; Schwarz DS; Keene A; Affar el B; Fenton L; Xia X; Shi Y; Zamore PD; Xu Z
Aging Cell; 2003 Aug; 2(4):209-17. PubMed ID: 12934714
[TBL] [Abstract][Full Text] [Related]
6. Allele-specific RNAi selectively silences mutant SOD1 and achieves significant therapeutic benefit in vivo.
Xia X; Zhou H; Huang Y; Xu Z
Neurobiol Dis; 2006 Sep; 23(3):578-86. PubMed ID: 16857362
[TBL] [Abstract][Full Text] [Related]
7. A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites.
Du Q; Thonberg H; Wang J; Wahlestedt C; Liang Z
Nucleic Acids Res; 2005; 33(5):1671-7. PubMed ID: 15781493
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic gene silencing delivered by a chemically modified small interfering RNA against mutant SOD1 slows amyotrophic lateral sclerosis progression.
Wang H; Ghosh A; Baigude H; Yang CS; Qiu L; Xia X; Zhou H; Rana TM; Xu Z
J Biol Chem; 2008 Jun; 283(23):15845-52. PubMed ID: 18367449
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the RNA Interference Activity Using Central Mismatched siRNAs and Acyclic Threoninol Nucleic Acids (aTNA) Units.
Alagia A; Terrazas M; Eritja R
Molecules; 2015 Apr; 20(5):7602-19. PubMed ID: 25919280
[TBL] [Abstract][Full Text] [Related]
10. [RNAi and neurological disease].
Yokota T
Rinsho Shinkeigaku; 2005 Nov; 45(11):973-5. PubMed ID: 16447777
[TBL] [Abstract][Full Text] [Related]
11. Designing of highly effective complementary and mismatch siRNAs for silencing a gene.
Ahmed F; Raghava GP
PLoS One; 2011; 6(8):e23443. PubMed ID: 21853133
[TBL] [Abstract][Full Text] [Related]
12. Palmitic acid-conjugated 21-nucleotide siRNA enhances gene-silencing activity.
Kubo T; Yanagihara K; Takei Y; Mihara K; Morita Y; Seyama T
Mol Pharm; 2011 Dec; 8(6):2193-203. PubMed ID: 21985606
[TBL] [Abstract][Full Text] [Related]
13. Effects on RNA interference in gene expression (RNAi) in cultured mammalian cells of mismatches and the introduction of chemical modifications at the 3'-ends of siRNAs.
Hamada M; Ohtsuka T; Kawaida R; Koizumi M; Morita K; Furukawa H; Imanishi T; Miyagishi M; Taira K
Antisense Nucleic Acid Drug Dev; 2002 Oct; 12(5):301-9. PubMed ID: 12477280
[TBL] [Abstract][Full Text] [Related]
14. Influence of assembly of siRNA elements into RNA-induced silencing complex by fork-siRNA duplex carrying nucleotide mismatches at the 3'- or 5'-end of the sense-stranded siRNA element.
Ohnishi Y; Tokunaga K; Hohjoh H
Biochem Biophys Res Commun; 2005 Apr; 329(2):516-21. PubMed ID: 15737617
[TBL] [Abstract][Full Text] [Related]
15. An RNAi strategy for treatment of amyotrophic lateral sclerosis caused by mutant Cu,Zn superoxide dismutase.
Xia XG; Zhou H; Zhou S; Yu Y; Wu R; Xu Z
J Neurochem; 2005 Jan; 92(2):362-7. PubMed ID: 15663483
[TBL] [Abstract][Full Text] [Related]
16. Modified siRNA structure with a single nucleotide bulge overcomes conventional siRNA-mediated off-target silencing.
Dua P; Yoo JW; Kim S; Lee DK
Mol Ther; 2011 Sep; 19(9):1676-87. PubMed ID: 21673662
[TBL] [Abstract][Full Text] [Related]
17. [Gene therapy of ALS with short interfering RNA].
Yokota T
Brain Nerve; 2007 Oct; 59(10):1187-94. PubMed ID: 17969360
[TBL] [Abstract][Full Text] [Related]
18. Effect of siRNA terminal mismatches on TRBP and Dicer binding and silencing efficacy.
Kini HK; Walton SP
FEBS J; 2009 Nov; 276(22):6576-85. PubMed ID: 19811537
[TBL] [Abstract][Full Text] [Related]
19. Profiling of mismatch discrimination in RNAi enabled rational design of allele-specific siRNAs.
Huang H; Qiao R; Zhao D; Zhang T; Li Y; Yi F; Lai F; Hong J; Ding X; Yang Z; Zhang L; Du Q; Liang Z
Nucleic Acids Res; 2009 Dec; 37(22):7560-9. PubMed ID: 19815667
[TBL] [Abstract][Full Text] [Related]
20. Allele-specific silencing of a pathogenic mutant acetylcholine receptor subunit by RNA interference.
Abdelgany A; Wood M; Beeson D
Hum Mol Genet; 2003 Oct; 12(20):2637-44. PubMed ID: 12928480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
